The pharmaceutical sector is currently at the heart of a radical transformation, primarily driven by the growing integration of Artificial Intelligence (AI) and connected technologies. These technological innovations are redefining not only the internal operations of pharmacies but also their interaction with patients. A significant investment of $100 million by Evernorth, a subsidiary of Cigna, in the Pharmacy Forward program, illustrates this trend. This program aims to enhance the efficiency of pharmaceutical processes through AI, although the concrete results have yet to be demonstrated. This dynamic raises critical questions about the real impact of AI on SMEs in the sector.
Débloquez l'Analyse Complète
Accédez instantanément à nos insights exclusifs générés par IA, basés sur l'agrégation de centaines de sources sectorielles.
